Evaluation of Gut Microbiota Predictive Potential Associated with Phenotypic Characteristics to Identify Multifactorial Diseases
Overview
Authors
Affiliations
Design: We assessed 50 healthy and 152 unhealthy individuals for phenotypic variables (PV) and gut microbiota (GM) composition by 16S rRNA gene sequencing. The entire modeling process was conducted in the R environment using the Random Forest algorithm. Model performance was assessed through ROC curve construction.
Results: We evaluated 52 bacterial taxa and pre-selected PV ( < 0.05) for their contribution to the final models. Across all diseases, the models achieved their best performance when GM and PV data were integrated. Notably, the integrated predictive models demonstrated exceptional performance for rheumatoid arthritis (AUC = 88.03%), type 2 diabetes (AUC = 96.96%), systemic lupus erythematosus (AUC = 98.4%), and type 1 diabetes (AUC = 86.19%).
Conclusion: Our findings underscore that the selection of bacterial taxa based solely on differences in relative abundance between groups is insufficient to serve as clinical markers. Machine learning techniques are essential for mitigating the considerable variability observed within gut microbiota. In our study, the use of microbial taxa alone exhibited limited predictive power for health outcomes, while the integration of phenotypic variables into predictive models substantially enhanced their predictive capabilities.
Bai B, Luo L, Yao F, Sun Q, Chen X, Zheng W Front Cell Infect Microbiol. 2024; 14:1452480.
PMID: 39660282 PMC: 11629706. DOI: 10.3389/fcimb.2024.1452480.
Luz V, Pereira S Front Med Technol. 2024; 6:1413637.
PMID: 39355139 PMC: 11444026. DOI: 10.3389/fmedt.2024.1413637.
From the Gut to the Brain: Is Microbiota a New Paradigm in Parkinson's Disease Treatment?.
Vilela C, Araujo B, Soares-Guedes C, Caridade-Silva R, Martins-Macedo J, Teixeira C Cells. 2024; 13(9.
PMID: 38727306 PMC: 11083070. DOI: 10.3390/cells13090770.